Company release

Nanoform Finland Plc

June 14, 2024

17.01 Finnish time / 16.01 Swedish time

Nanoform Finland Plc - Manager's Transactions - Jeanne Thoma

Helsinki, Finland - Manager's transaction related to Nanoform Finland Plc's Member of the Board Jeanne Thoma's purchase of Nanoform Finland Plc shares:

Nanoform Finland Oyj - Managers' Transactions

Person subject to the notification requirement

Name: Jeanne Thoma

Position: Member of the Board/Deputy member

 Issuer: Nanoform Finland Oyj

LEI: 743700JJO2NU8LBS1592

Notification type: INITIAL NOTIFICATION

Reference number: 65899/19/10

Transaction date: 2024-06-14

Outside a trading venue

Instrument type: SHARE

ISIN: FI4000330972

Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details

(1): Volume: 19402 Unit price: 0 EUR

Aggregated transactions (1):

Volume: 19402 Volume weighted average price: 0 EUR

For further information, please contact:

Peter Hänninen

General Counsel

peter.hanninen@nanoform.com

+358 50 353 0408

For investor relations queries, please contact:

Henri von Haartman

Director of Investor Relations

hvh@nanoform.com

+46 7686 650 11

About NanoformNanoform is the medicine performance-enhancing company that leverages best-in-class innovative nanoparticle engineering technologies, expert formulation, and scalable GMP nano-API manufacturing to enable superior medicines for patients. The company focuses on reducing clinical attrition and on enhancing drug molecules' performance through its nanoforming technologies and formulation services, from pre-clinical to commercial scale. Nanoform will help improve bioavailability and drug delivery profiles, drive differentiation, patient adherence and extend the lifecycle potential of products. Nanoform's shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). Certified Adviser: Danske Bank A/S, Finland Branch, +358 40 744 1900. For more information, please visit www.nanoform.com.